1
$\begingroup$

Lets say I have a pharmaceutical "P". It can be broken down by enzymes of one strain of bacteria into two molecules one of which can be further metabolized enzymatically by a different strain of bacteria. Both strains as a result can decompose "P" to the simplest metabolites.

Could one hope to reverse the reaction using the same enzymes and have the two bacteria produce "P" from basic nutrients and if so, how would the conditions have to be altered? Or perhaps would it be possible ex vivo?

|improve this question
$\endgroup$
  • 1
    $\begingroup$ Why are you complicating your question with two bacterial strains. As far as I can see, your question is whether a series of reactions that degrade a xenobiotic could be used to synthesize it, presumably on the premise that all reactions are reversible. Or do I misunderstand you? $\endgroup$ – David May 12 '19 at 16:51
  • $\begingroup$ You're quite right, however i will clarify that the core of the question is whether enzymes could too strongly affect the reversibility/equillibrium of the reactions, and if not, could this be done with living organisms or perhaps ex vivo? Also since i read about a pharmaceutical decomposed only by a certain two strain coculture i wonder if it would affect the answer in that case. $\endgroup$ – Francis L. May 12 '19 at 17:25
  • $\begingroup$ After posting I realized that you must have a particular situation in mind. My immediate reaction is that it won’t work because of the thermodynamics of synthesis and degradation pathways and the different enzyme specificity required. However I never answer questions in comments. If you need this explaining I’ll do so if nobody else does. But it may be a few days as I have other fish to fry at the moment. $\endgroup$ – David May 12 '19 at 18:44
0
$\begingroup$

In principle yes, because almost all reactions exist in an equilibrium and enzymes are catalysts (meaning they affect mainly the activation energy for a specific reaction).

The best approach is to purify the enzymes in question (probably not even from their original species, but from another transgenic bacterium), since this reduces your total systems from two different organisms and all their enzymes and metabolites to a very specific set of two enzymes and a handful of metabolites.

But ...

  • The natural equilibrium of the reaction might favor the more basic metabolites.
    Even if you speed up the generation of "P", that won't help much if only a fraction is converted in the first place. Many biological systems deal with this problem by coupling unfavourable steps with hydrolysis of high energy molecules (like ATP), but linking to this to a given enzyme would be a very challenging process.
  • The enzyme(s) might not be overly specific for "P".
    Many enzymes that remove or break down 'unwanted' products can act on multiple similar molecules. This make sense for cells, since its much more efficient to have one enzyme taking care of multiple 'bad things'. However, this makes reversing the process tricky since your reaction will yield multiple products of which only one is interesting. Optimising the enzyme to be more specific is relatively straight forward using in vitro evolution though.
  • 'Basic metabolites' is not a clearly defined thing.
    Many pharmaceuticals are pretty complex, and enzymes that break them down likely literally chop it into two pieces. Whether these pieces are actually easy to obtain chemicals that can be used as input for an enzymatic reaction is a different question. Depending on the complexity of 'P' you might have to use a pretty large number of enzymes (all of which may come with the above mentioned problems) to be able to start from reasonably basic molecules.
|improve this answer
$\endgroup$

Your Answer

By clicking “Post Your Answer”, you agree to our terms of service, privacy policy and cookie policy

Not the answer you're looking for? Browse other questions tagged or ask your own question.